Search research articles
Contact Us
Filters
Showing results (91-100 of 193) with videos related to
Page
of 20
Sort By:
Blood Advances
|
November 5, 2025
UBE2O AS A KEY REGULATOR OF DRUG-INDUCED ERYTHROPOIESIS IN THE CONTEXT OF MYELODYSPLASTIC SYNDROMES
Beatrice Maffeo, Cristina Panuzzo, Arianna Savi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2006
First case of an AIDS patient with systemic mast cell disease associated with FIP1-positive eosinophilia treated with imatinib mesylate therapy
Serena Merante, Merante Serena, Guido Chichino, et al.
Cancer
|
August 27, 2004
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation
Daniela Cilloni, Francesca Messa, Enrico Gottardi, et al.
Oncotarget
|
December 30, 2016
A novel assay to detect calreticulin mutations in myeloproliferative neoplasms
Valentina Rosso, Jessica Petiti, Enrico Bracco, et al.
Journal of Clinical Medicine
|
August 26, 2023
Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey
Massimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, et al.
British Journal of Haematology
|
July 10, 2018
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib
Elena Crisà, Daniela Cilloni, Elena M Elli, et al.
American Journal of Hematology
|
June 20, 2015
Development of cellular and humoral response against WT1 protein vaccination in mice
Paolo Nicoli, Chiara Calabrese, Rosa Maria Pellegrino, et al.
Leukemia & Lymphoma
|
May 10, 2017
Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study
Emanuela Messa, Lucia Biale, Anna Castiglione, et al.
Oncotarget
|
October 22, 2016
Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detection
Sonia Carturan, Jessica Petiti, Valentina Rosso, et al.
Journal of Clinical Medicine
|
May 17, 2020
Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical <i>BCR-ABL1</i> Transcripts
Jessica Petiti, Marco Lo Iacono, Matteo Dragani, et al.
Page
of 20
Search research articles
Search
Showing results (91-100 of 193) with videos related to
Sort By:
Page
of 20
Blood Advances
|
November 5, 2025
UBE2O AS A KEY REGULATOR OF DRUG-INDUCED ERYTHROPOIESIS IN THE CONTEXT OF MYELODYSPLASTIC SYNDROMES
Beatrice Maffeo, Cristina Panuzzo, Arianna Savi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2006
First case of an AIDS patient with systemic mast cell disease associated with FIP1-positive eosinophilia treated with imatinib mesylate therapy
Serena Merante, Merante Serena, Guido Chichino, et al.
Cancer
|
August 27, 2004
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation
Daniela Cilloni, Francesca Messa, Enrico Gottardi, et al.
Oncotarget
|
December 30, 2016
A novel assay to detect calreticulin mutations in myeloproliferative neoplasms
Valentina Rosso, Jessica Petiti, Enrico Bracco, et al.
Journal of Clinical Medicine
|
August 26, 2023
Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey
Massimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, et al.
British Journal of Haematology
|
July 10, 2018
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib
Elena Crisà, Daniela Cilloni, Elena M Elli, et al.
American Journal of Hematology
|
June 20, 2015
Development of cellular and humoral response against WT1 protein vaccination in mice
Paolo Nicoli, Chiara Calabrese, Rosa Maria Pellegrino, et al.
Leukemia & Lymphoma
|
May 10, 2017
Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study
Emanuela Messa, Lucia Biale, Anna Castiglione, et al.
Oncotarget
|
October 22, 2016
Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detection
Sonia Carturan, Jessica Petiti, Valentina Rosso, et al.
Journal of Clinical Medicine
|
May 17, 2020
Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical <i>BCR-ABL1</i> Transcripts
Jessica Petiti, Marco Lo Iacono, Matteo Dragani, et al.
Page
of 20